TY  - JOUR
AU  - López-Cano, Carolina
AU  - Ciudin, Andreea
AU  - Sánchez, Enric
AU  - Tinahones, Francisco J
AU  - Barbé, Ferran
AU  - Dalmases, Mireia
AU  - García-Ramírez, Marta
AU  - Soto, Alfonso
AU  - Gaeta, Anna Michela
AU  - Pellitero, Silvia
AU  - Martí, Raquel
AU  - Hernández, Cristina
AU  - Simó, Rafael
AU  - Lecube, Albert
PY  - 2022
DO  - 10.2337/db21-0688
UR  - http://hdl.handle.net/10668/20499
T2  - Diabetes
AB  - To evaluate the effect of liraglutide, a glucagon-like peptide 1 receptor agonist, on pulmonary function and serum levels of surfactant protein D (SP-D) in type 2 diabetes. A double-blind, randomized, crossover, placebo-controlled clinical trial...
LA  - en
KW  - Aged
KW  - Blood Glucose
KW  - Cross-Over Studies
KW  - Diabetes Mellitus, Type 2
KW  - Double-Blind Method
KW  - Female
KW  - Glycemic Control
KW  - Humans
KW  - Liraglutide
KW  - Lung
KW  - Male
KW  - Middle Aged
KW  - Pulmonary Surfactant-Associated Protein D
KW  - Spain
KW  - Vital Capacity
TI  - Liraglutide Improves Forced Vital Capacity in Individuals With Type 2 Diabetes: Data From the Randomized Crossover LIRALUNG Study.
TY  - research article
VL  - 71
ER  -